Obstetric cholestasis: May have serious consequences for the fetus, and needs to be taken seriously

BMJ

Volumn 324, Issue 7330, 2002, Pages 123-124

  Milkiewicz, Piotr ^a   Elias, Elwyn ^a   Williamson, Catherine ^b   Weaver, Judith ^c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; BILE ACID; BILE SALT; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 3; PHOSPHOLIPID; PROGESTERONE; URSODEOXYCHOLIC ACID; ABC TRANSPORTER; CARRIER PROTEIN; GLYCOPROTEIN P;

AMINO ACID SUBSTITUTION; BILE ACID BLOOD LEVEL; BILE SECRETION; CHOLESTASIS; CHOLESTEROL STONE; DISEASE PREDISPOSITION; EDITORIAL; FAMILIAL DISEASE; FETUS DEATH; FETUS DISTRESS; GENE MUTATION; HUMAN; INCIDENCE; INHERITANCE; LIVER FUNCTION TEST; OBSTETRIC CHOLESTASIS; PATHOPHYSIOLOGY; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PRURITUS; SECOND TRIMESTER PREGNANCY; STILLBIRTH; THIRD TRIMESTER PREGNANCY; BLOOD; FEMALE; FETUS HYPOXIA; GENETICS; INTRAHEPATIC CHOLESTASIS; METABOLISM; MUTATION; PREGNANCY; PREGNANCY COMPLICATION;

ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; CARRIER PROTEINS; CHOLESTASIS, INTRAHEPATIC; FEMALE; FETAL HYPOXIA; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MUTATION; P-GLYCOPROTEINS; PREGNANCY; PREGNANCY COMPLICATIONS; PROGESTERONE; PRURITUS;

EID: 0037132818     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.324.7330.123     Document Type: Editorial

References (14)

1. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 1012–1021.
2. Reid R, Ivey KJ, Rencoret RH, Storey B. Fetal complications of obstetric cholestasis. BMJ 1976; 1: 870–872.
3. Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, et al. Prevalence of intrahepatic cholestasis in Chile. Ann Intern Med 1978; 487–93.
4. Meng LJ, Reyes H, Palma J, et al. Effects of ursodeoxycholec acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol 1997; 27: 1029–1040.
5. Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210–211.
6. Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9: 1209–1217.
7. Eleoranta MJ, Heinonen S, Mononen T, Saarikoski S. Risk of obstetric cholestasis in sisters of index patients. Clin Genet 2001; 60: 42–45.
8. Williamson C, Gorelik J, Eaton BM, Lab M, de Swiet M, Korchev Y. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin Sci 2001; 100: 363–369.
9. Campos GA, Guerra FA, Israel EJ. Effects of cholic acid infusion in fetal lambs. Acta Obstet Gynecol Scand 1986; 65: 23–26.
10. Milkiewicz P, Gallagher R, Eggington E, Kilby M, Weaver JB, Elias E. Obstetric cholestasis with elevated GGT: incidence, presentation and treatment. Hepatology 2001; 34: A364
11. Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 1995; 37: 580–584.
12. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double blind study controlled with palcebo. J Hepatol 1997; 27: 1022–1028.
13. Elias E. URSO in obstetric cholestasis: not a bear market. Gut 1999; 45: 331–332.
14. Brites D, Rodrigues CM. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy. J Hepatol 1998; 29: 743–751.